These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7644063)

  • 41. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport.
    Nutt JG; Woodward WR; Hammerstad JP; Carter JH; Anderson JL
    N Engl J Med; 1984 Feb; 310(8):483-8. PubMed ID: 6694694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response to brief levodopa infusions in parkinsonian patients with and without motor fluctuations.
    Gancher ST; Nutt JG; Woodward W
    Neurology; 1988 May; 38(5):712-6. PubMed ID: 3362366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interactions between deep brain stimulation and levodopa in Parkinson's disease.
    Nutt JG; Rufener SL; Carter JH; Anderson VC; Pahwa R; Hammerstad JP; Burchiel KJ
    Neurology; 2001 Nov; 57(10):1835-42. PubMed ID: 11723273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease.
    Mouradian MM; Heuser IJ; Baronti F; Chase TN
    Ann Neurol; 1990 Jan; 27(1):18-23. PubMed ID: 2301923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study.
    Hardie RJ; Lees AJ; Stern GM
    Brain; 1984 Jun; 107 ( Pt 2)():487-506. PubMed ID: 6722513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prosody and levodopa in Parkinson's disease.
    Azevedo LL; Reis CA; Souza IS; Cardoso FE
    Arq Neuropsiquiatr; 2013 Nov; 71(11):835-40. PubMed ID: 24394867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease.
    Stocchi F; Ruggieri S; Vacca L; Olanow CW
    Brain; 2002 Sep; 125(Pt 9):2058-66. PubMed ID: 12183351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.
    Lou JS; Kearns G; Benice T; Oken B; Sexton G; Nutt J
    Mov Disord; 2003 Oct; 18(10):1108-14. PubMed ID: 14534913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intravenous infusion of L-dopa: current prospective therapies].
    Peppe A; De Angelis D; Tolli VS; Rizzo PA; Scoppetta C
    Riv Neurol; 1991; 61(5):197-200. PubMed ID: 1808680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The dopaminergic response in multiple system atrophy.
    Hughes AJ; Colosimo C; Kleedorfer B; Daniel SE; Lees AJ
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1009-13. PubMed ID: 1469394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term levodopa in Parkinson's disease.
    Yahr MD
    Lancet; 1977 Mar; 1(8013):706-7. PubMed ID: 66509
    [No Abstract]   [Full Text] [Related]  

  • 52. Combined bromocriptine-levodopa therapy early in Parkinson's disease.
    Rinne UK
    Neurology; 1985 Aug; 35(8):1196-8. PubMed ID: 4022354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Diurnal worsening in Parkinson patients treated with levodopa].
    Piccini P; Del Dotto P; Pardini C; D'Antonio P; Rossi G; Bonuccelli U
    Riv Neurol; 1991; 61(6):219-24. PubMed ID: 1813974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa.
    Leeman AL; O'Neill CJ; Nicholson PW; Deshmukh AA; Denham MJ; Royston JP; Dobbs RJ; Dobbs SM
    Br J Clin Pharmacol; 1987 Nov; 24(5):637-43. PubMed ID: 3325092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal monitoring of the levodopa concentration-effect relationship in Parkinson's disease.
    Contin M; Riva R; Martinelli P; Cortelli P; Albani F; Baruzzi A
    Neurology; 1994 Jul; 44(7):1287-92. PubMed ID: 8035932
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treating motor fluctuations with controlled-release levodopa preparations.
    Koller WC; Pahwa R
    Neurology; 1994 Jul; 44(7 Suppl 6):S23-8. PubMed ID: 8047257
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease.
    Sage JI; Schuh L; Heikkila RE; Duvoisin RC
    Clin Neuropharmacol; 1988 Feb; 11(1):36-44. PubMed ID: 3349496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of levodopa oral bolus on the kinematics of the pointing movements in Parkinson's disease patients.
    Camarda R; Camarda C; Grimaldi S; Camarda LK; Monastero R; Gangitano M
    J Neurol; 2005 Sep; 252(9):1074-81. PubMed ID: 15822002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term 24-h levodopa/carbidopa gel infusion in Parkinson's disease.
    Busk K; Nyholm D
    Parkinsonism Relat Disord; 2012 Sep; 18(8):1000-1. PubMed ID: 22546333
    [No Abstract]   [Full Text] [Related]  

  • 60. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.
    Mouradian MM; Juncos JL; Fabbrini G; Schlegel J; Bartko JJ; Chase TN
    Ann Neurol; 1988 Sep; 24(3):372-8. PubMed ID: 3228271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.